Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214025) titled 'Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children' on Sept. 26.
Study Type: Observational
Primary Sponsor: Assiut University
Condition:
Romiplostim N01
ITP
Intervention:
Drug: Safety and efficacy of Romiplostim in Treatment of chronic ITP in children
Recruitment Status: Not recruiting
Date of First Enrollment: November 1, 2025
Target Sample Size: 100
To know more, visit https://clinicaltrials.gov/study/NCT07214025
Published by HT Digital Content Services with permission from Health Daily Digest....